Fobi AI Responds To CTO (Cease Trade Order) Commitment To Financial Transparency and Audit Completion
November 01, 2024 19:41 ET | Source: Fobi AI Inc. VANCOUVER, BC,…
Legible Announces Appointment of Successor Auditor
November 01, 2024 18:00 ET | Source: Legible VANCOUVER, British Columbia, Nov.…
Intuitive Machines Announces Date for Third Quarter 2024 Financial Results Conference Call
HOUSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR,…
Nokia Corporation: Repurchase of own shares on 01.11.2024
Nokia CorporationStock Exchange Release1 November 2024 at 22:30 EET Nokia Corporation: Repurchase…
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024 19:04 ET | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Nov.…
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024 18:32 ET | Source: LENSAR, Inc. ORLANDO, Fla., Nov.…
HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access
November 01, 2024 18:14 ET | Source: HeartFlow Holding, Inc. — Hospital…
OnKure to Present Clinical and Preclinical Data for OKI-219 at the 2024 San Antonio Breast Cancer Symposium
November 01, 2024 17:30 ET | Source: OnKure Therapeutics, Inc. OnKure to…
ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- ALX Oncology…
Optimal Breathing Holds its Annual Black Friday Sale
FORT MILL, S.C., Nov. 02, 2024 (GLOBE NEWSWIRE) -- Optimal Breathing will…